Ignite Creation Date:
2024-05-05 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00261742
Status:
TERMINATED
Last Update Posted:
2007-01-17
First Post:
2005-12-01
Brief Title:
Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis
Sponsor:
University Childrens Hospital Basel
Organization:
University Childrens Hospital Basel
Study Overview
Official Title:
Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Dermatitis - an Open Randomized Controlled Trial
Status:
TERMINATED
Status Verified Date:
2007-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of the study is to investigate which of two antibiotic treatments - oral penicillin for 10 days or oral cefuroxim for 7 days - is more successful for patients 1-16 years of age with perianal dermatitis caused by group A beta-hemolytic streptococci
Detailed Description:
The goal of the study is to investigate which of two antibiotic treatments - oral penicillin for 10 days or oral cefuroxim for 7 days - is more successful for patients 1-16 years of age with perianal dermatitis caused by group A beta-hemolytic streptococci GABHS Diagnosis is based on positive perianal culture for GABHS Informed consent will be obtained
The study will be performed in the region of Basel Switzerland in private practices of pediatricians general practitioners and selected pediatric dermatologists as well as in the out-patient departments of the University Childrens Hospital Basel and the department for dermatology of the University of Basel
Patients or their parents will fill in a daily diary on signs and symptoms of disease furthermore clinical investigations inspection of the site of infection will be performed on enrollment Day 1 Day 3 and at the end of treatment Day 10
The study will be performed in the region of Basel Switzerland in private practices of pediatricians general practitioners and selected pediatric dermatologists as well as in the out-patient departments of the University Childrens Hospital Basel and the department for dermatology of the University of Basel
Patients or their parents will fill in a daily diary on signs and symptoms of disease furthermore clinical investigations inspection of the site of infection will be performed on enrollment Day 1 Day 3 and at the end of treatment Day 10
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None